Methodologies for antiviral efficacy and toxicity of drugs against new Covid-19
An Italian company, highly skilled in all preclinical stages of compound development, drug development and drug combination studies, has implemented a series of methodologies to study antiviral efficacy and toxicity of drugs, against new coronavirus SARS-CoV-2, having access to different viral strains for testing. The Italian company is interested in commercial agreements with technical assistance, technical or research collaborations.